Markets

Markets Overview Market Context

Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Market Context Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Live News EQUITY FLASH M impact Oct 14, 2026, 10:23 AM UTC

Infomina Reports Q1 Attributable Profit of 10.55 Million Ringgit

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

INFOM

Related stories

United Therapeutics, Liquidia Settle Patent Litigation With $330.4M Payment The settlement includes a $330.4 million aggregate payment to United Therapeutics and actions to remove the PH-ILD indication from Yutrepia’s label. M impact | EQUITY | Oct 14, 2026, 11:13 AM UTC Jeil M&S largest shareholder shifts to FG Investment No.3 with 79.91% stake Jeil M&S’ largest shareholder shifted to FG Investment No.3 with 31,000,000 shares, equal to 79.91% voting rights. Former top holder group led by Lee Youngjin cut to 571,800 shares L impact | EQUITY | Oct 14, 2026, 11:06 AM UTC Calian Awarded CAD$47 Million NATO Contract for Scenario Development Calian says the five-year contract is for scenario development at NATO’s Joint Warfare Centre. M impact | EQUITY | Oct 14, 2026, 11:06 AM UTC Cushman & Wakefield says India ranks top in global flexible office market maturity index Cushman & Wakefield flagged flexible office as a core real estate strategy as demand broadened across regions. Upflex data showed the U.S. led global bookings with a 38.7% share in L impact | EQUITY | Oct 14, 2026, 11:06 AM UTC Viking Therapeutics Starts Phase 3 Trial Program for Oral VK2735 in Obesity The company announced initiation of its oral VK2735 Phase 3 clinical program in patients with obesity. L impact | EQUITY | Oct 14, 2026, 11:05 AM UTC Humana Medicare Advantage policy covers AngioDynamics NanoKnife IRE AngioDynamics says Humana’s Medicare Advantage coverage policy supports broader access to NanoKnife IRE for prostate and liver cancer. L impact | EQUITY | Oct 14, 2026, 11:03 AM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.